InvestorsHub Logo

cowtown jay

10/16/23 2:41 PM

#40736 RE: sosjtb #40735

I don't drink, but I'm looking forward to a cocktail. The nice thing about that is that our market will be increased beyond lenz being used just as a therapeutic, but also used by totally asymptomatic people trying to protect themselves from covid by taking a Nuvaxovid vaccine with lenz.

Maybe this is why the EU wants to look at additional Novavax data over the next four weeks or so.

https://www.reuters.com/business/healthcare-pharmaceuticals/eu-delays-approval-novavaxs-revised-covid-vaccine-ft-2023-10-15/

Novavax has had the motive and the opportunity to use lenz with their vaccine, at least to some extent.

Regardless, I think our management is very interested in an opportunity with Novavax.